Status:
COMPLETED
The Impact of Intervention With High-protein Enteral Formula in SICU.
Lead Sponsor:
Tungs' Taichung Metroharbour Hospital
Conditions:
Enteral Nutrition
Critical Illness
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The advantage of higher protein intake has been pointed for critically ill patients. However, it is not easy to achieve no overfeeding but adequate protein intakes for critically ill patients. It is t...
Detailed Description
Trial Design and Patient Population This study is an investigator-initiated, prospective, randomized controlled trial. This study is conducted according to the guidelines laid down in the Declaration...
Eligibility Criteria
Inclusion
- 20 years of age or older.
- Those who have stayed in the surgical intensive care unit for 24 hours or more.
Exclusion
- Those who cannot supply enteral nutrition within 3 days due to disease or unstable clinical conditions.
- Those who have been fed for less than three days due to disease or unstable clinical conditions.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT04868318
Start Date
May 10 2021
End Date
December 31 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PS Lim
Taichung, Taiwan, 435